|1.||Sakuma, Shinji: 6 articles (07/2015 - 10/2008)|
|2.||Yamashita, Shinji: 5 articles (03/2015 - 10/2008)|
|3.||Pham, Wellington: 4 articles (07/2015 - 11/2011)|
|4.||Kataoka, Makoto: 4 articles (03/2015 - 10/2008)|
|5.||Masaoka, Yoshie: 4 articles (03/2015 - 10/2008)|
|6.||Margel, Shlomo: 4 articles (01/2014 - 01/2012)|
|7.||Hiwatari, Ken-ichiro: 4 articles (12/2011 - 10/2008)|
|8.||Gore, John C: 3 articles (07/2015 - 11/2011)|
|9.||Kumagai, Hironori: 3 articles (07/2015 - 11/2011)|
|10.||Hoffman, Robert M: 3 articles (03/2015 - 03/2010)|
|1.||Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
02/01/1991 - "A comparison study of two methods of peanut agglutinin staining with S100 immunostaining in 29 cases of histiocytosis X."
05/01/1990 - "A comparison study of two methods of peanut agglutinin staining with S100 immunostaining in 29 cases of histiocytosis X (Langerhans' cell histiocytosis)"
07/01/1993 - "The diagnosis of histiocytosis X was made on the basis of the positive immunoperoxidase staining of the histiocytic cells with S-100 and peanut agglutinin (PNA) as well as the clinical picture. "
09/01/1992 - "In contrast, most histiocytosis X cells labeled for S100 protein and with LN3 and peanut agglutinin. "
03/01/1987 - "The usefulness of peanut agglutinin for the detection of histiocytosis-X and interdigitating reticulum cells."
01/01/2012 - "Conjugation of peanut agglutinin or αCEA to the nanoparticles significantly increased the fluorescence intensity of the tagged colon tumor tissues relative to the nonconjugated nanoparticles."
10/01/2011 - "Cancer associated aberrant glycosylation likely represents the determining cause of peanut agglutinin selectivity. "
08/01/2009 - "In vitro, TF-Ag peptide mimics bound to TF-Ag-specific peanut agglutinin and blocked TF-Ag-mediated rolling and stable adhesion of cancer cells to vascular endothelium. "
05/01/2001 - "Immunohistochemical staining of primary tumors showed the presence of peanut agglutinin binding (PNA(+)) highly mitotic lymphoblasts, suggesting their GC derivation. "
01/01/1992 - "Differential expression of malignant phenotypes by these cell lines prompted us to examine their expression of carbohydrate structures binding peanut agglutinin (PNA), soy bean agglutinin (SBA) or leukoagglutinin (L-PHA), which are known indicators of tumor progression in rodents and humans. "
05/15/1995 - "Staining for wheat germ agglutinin and peanut agglutinin was weakly positive or negative in normal and hyperplastic glands, whereas it was strongly positive in dysplasia and carcinoma. "
12/01/1990 - "The location of Peanut agglutinin (PNA), Bandeiraea Simplicifolia (BSL) and UEA1 in breast carcinomas exhibited some regularity and it might be useful in understanding the differentiation of breast carcinomas. "
07/01/1990 - "The results showed that Bandeiraea Simplicifolia (BSL) and Peanut agglutinin (PNA) had higher positive rates in breast carcinoma than both normal breast and benign breast lesions (P less than 0.005). "
06/01/1990 - "[Peanut lectin-binding sites in gastric carcinoma and the adjacent mucosa]."
04/01/1990 - "[Immunohistochemical and immunoelectron microscopic observation of human lung carcinomas using biotinized peanut lectin (PNA)]."
|4.||Breast Neoplasms (Breast Cancer)
01/01/1988 - "Peanut agglutinin inhibits proliferation of cultured breast cancer cells."
01/01/1983 - "Peanut agglutinin (PNA) binding sites: a useful marker for hormonal dependence in experimental breast cancer."
10/01/2014 - "Here, the binding of two markers that recognize Galβ1-3GalNAc (peanut lectin and mAb A78-G/A7) was elevated in breast tumor, but not in normal control, only upon sialidase treatment. "
03/26/2013 - "GNS/C60 inclusion complexes are able to establish specific interactions between peanut agglutinin (PNA) lectin and the lactose moiety surrounding the complexes, while CPT solubilized by GNS shows higher cytotoxicity toward MCF7-type breast cancer cells than CPT alone. "
01/01/1988 - "Cultured breast cancer cells express on their surface glycoproteins which are recognized by the peanut lectin (PNA). "
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/01/1995 - "PNA (Peanut agglutinin) specifically stained cell membranes of middle layer and basal cells in the normal squamous epithelium and epithelial dysplasias, but in squamous cell carcinomas, a lack of cell membrane staining of various degrees was noted. "
02/01/1990 - "Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma."
02/01/1989 - "Wheat germ agglutinin and peanut agglutinin displayed intense cytoplasmic and/or membrane binding in more than 90% of the carcinoma in situ and squamous cell carcinoma specimens. "
02/28/2000 - "T-antigen expressions were measured by the enzyme-linked lectin assay (ELLA) with peanut agglutinin (PNA) in the sera of patients with squamous cell carcinoma (SCC) of the uterine cervix from 286 patients. "
04/01/1986 - "II. Masking of peanut agglutinin (PNA) binding sites in solar keratoses, Bowen's disease, and squamous cell carcinoma by neuraminic acid."
|2.||S100 Proteins (S 100 Protein)
|4.||HLA-DR Antigens (HLA-DR)
|2.||Heterologous Transplantation (Xenotransplantation)